Faizullina, L. Kh.,
Karamisheva, L. Sh.,
Yakupova, L. R.,
Migranov, A. R.,
Saifullin, R. L.,
Valeev, F. A.,
Valiullina, Z. A.,
Samorodov, A. V. (2024) at the
level of aspirin. The antioxidant
activity of the synthesized compounds was assessed from the rate
Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) The main goal of applying antiplatelet drugs is a reduced probability of thrombosis so that
activeSultanova, R.M.,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Samorodov, A.V.,
Zlotskii, S.S. (2023) . The synthesized 2-substituted 4,5-dihydro-1H-imidazoles were found to possess the antiplatelet
activity synthesized by reaction of III with organic and inorganic bases. Compounds possessing antiaggregant
activityBogdanov, A.V.,
Andreeva, O.V.,
Belenok, M.G.,
Voloshina, A.D.,
Enikeeva, K.I.,
Samorodov, A.V.,
Mironov, V.F. (2021) and have a significant antiaggregatory and anticoagulant
activity at the
level of reference drugs
Sultanova, R.M.,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Samorodov, A.V.,
Zlotsky, S.S. (2023) with hindered carboxyl groups. It was found that the synthesized esters have anti-aggregation
activity-crown-6 ether in toluene. In vitro anticoagulant and antiplatelet
activity of the adduct was studied
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the antiplatelet, anticoagulant, and antioxidant
activity revealed promising compounds
Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) ) derivatives and evaluated their anti-inflammatory
activities by measuring the release of cytokines